Delivery Order SPE2DB22D9143-SPE2DB25FZC81
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $33,000 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units) with an ultimate completion date of September 22, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million single-award contract valid through November 2026 that enables the agency to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,265.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 20 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a direct pharmaceutical supply fulfillment under DLA's pharmaceutical distribution operations. DMS...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $16,483.21 for Cabometyx 40 mg tablets (30-count units). The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,434.34 by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Cabometyx 60 mg tablets (30-count packaging). This firm fixed-price delivery order, which has an ultimate completion date of September 19, 2025, represents a single pharmaceutical product delivery under the company's existing indefinite delivery contract...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by August 20, 2025, and represents performance at the contractor's Park Ridge facility. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count). The delivery order, issued on September 5, 2025, with completion targeted for September 8, 2025, is structured as a firm fixed-price contract with no set-aside designation. This award represents a single transaction under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $32,868.70 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 60 mg tablets (30-count units). This firm fixed-price delivery order, issued on September 19, 2025, represents fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and extending through November 2026. The delivery is scheduled for completion by...
- The U.S. Defense Logistics Agency awarded a delivery order valued at $16,483.21 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units). This award, issued on August 19, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois. The contract utilizes no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $33,265.08 by the Defense Logistics Agency on September 19, 2025, for the supply of Cabometyx 20 mg tablets (30-count units). The contract, which carries no set-aside designation, is scheduled for completion by September 22, 2025, and is performed at the contractor's Park Ridge location. This delivery order is issued under...
- SPE2DB22D9143Indefinite Delivery Contract
- SPE2DB22D9143-SPE2DB25FZC81Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc. for the supply of Cabometyx 40 mg tablets (30-count units) on September 17, 2025, with completion targeted for September 18, 2025. This firm fixed-price delivery order, issued without a set-aside designation, leverages DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting Department of Defense medical supply requirements. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations as a woman-owned small business. DMS Pharmaceutical Group Inc. serves as a critical pharmaceutical wholesaler within the federal supply chain, specializing in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. The company's extensive federal contract portfolio demonstrates its capability to deliver specialized pharmaceutical products, including oncology treatments such as Cabometyx, across the military health system. As a woman-owned small business registered in SAM.gov since 2001, DMS Pharmaceutical Group has consistently secured contracts through competitive procurement, establishing itself as a reliable supplier for the Defense Logistics Agency's pharmaceutical distribution requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.0k | 9/17/25 |